Enterprise Value
95.37M
Cash
606.4M
Avg Qtr Burn
-35.88M
Short % of Float
24.52%
Insider Ownership
7.75%
Institutional Own.
98.55%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
VERVE-102 (PCSK9) Details Hypercholesterolemia | Phase 1b Data readout | |
VERVE-101 (PCSK9) Details Hypercholesterolemia | Phase 1b Data readout | |
VERVE-201 (ANGPTL3) Details Hypercholesterolemia | Phase 1b Initiation |